Induction of telomerase activity during development of human mast cells from peripheral blood CD34+ cells:: Comparisons with tumor mast-cell lines

被引:25
作者
Chaves-Dias, C
Hundley, TR
Gilfillan, AM
Kirshenbaum, AS
Cunha-Melo, JR
Metcalfe, DD
Beaven, MA
机构
[1] NHLBI, Immunol Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.166.11.6647
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To further characterize the development of mast cells from human hemopoietic pluripotent cells we have investigated the expression of telomerase activity in cultured human peripheral blood CD34(+) cells, and CD34(+)/CD117(+)/CD13(+) progenitor mast cells selected therefrom, with the idea that induction of telomerase is associated with clonal expansion of CD34(+)/CD117(+)/CD13(+) cells. A rapid increase in telomerase activity preceded proliferation of both populations of cells in the presence of stern Cell factor and either IL-3 or IL-6. The induction was transient, and telomerase activity declined to basal levels well before the appearance of mature mast cells. Studies with pharmacologic inhibitors suggested that this induction was initially dependent on the p38 mitogen-activated protein kinase and phosphatidylinositol 3 ' -kinase, but once cell replication was underway telomerase activity, but not cell replication, became resistant to the effects of inhibitors. Tumor mast cell lines, in contrast, expressed persistently high telomerase activity throughout the cell cycle, and this expression was unaffected by inhibitors of all known signaling pathways in mast cells even when cell proliferation was blocked for extended periods. These results suggest that the transient induction of telomerase activity in human progenitor mast cells was initially dependent on growth factor-mediated signals, whereas maintenance of high activity in tumor mast cell lines was not dependent on intracellular signals or cell replication.
引用
收藏
页码:6647 / 6656
页数:10
相关论文
共 76 条
[11]   Telomerase regulation during entry into the cell cycle in normal human T cells [J].
Buchkovich, KJ ;
Greider, CW .
MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (09) :1443-1454
[12]   ESTABLISHMENT OF AN IMMATURE MAST-CELL LINE FROM A PATIENT WITH MAST-CELL LEUKEMIA [J].
BUTTERFIELD, JH ;
WEILER, D ;
DEWALD, G ;
GLEICH, GJ .
LEUKEMIA RESEARCH, 1988, 12 (04) :345-355
[13]   Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow [J].
Chiu, CP ;
Dragowska, W ;
Kim, NW ;
Vaziri, H ;
Yui, J ;
Thomas, TE ;
Harley, CB ;
Lansdorp, PM .
STEM CELLS, 1996, 14 (02) :239-248
[14]  
CHOI OH, 1993, J IMMUNOL, V151, P5586
[15]   Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells [J].
Cissel, DS ;
Beaven, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) :7066-7070
[16]   The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs) [J].
Clerk, A ;
Sugden, PH .
FEBS LETTERS, 1998, 426 (01) :93-96
[17]   Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization [J].
Counter, CM ;
Hahn, WC ;
Wei, WY ;
Caddle, SD ;
Beijersbergen, RL ;
Lansdorp, PM ;
Sedivy, JM ;
Weinberg, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14723-14728
[18]   Tyrosine kinase-deficient Wv c-kit induces mast cell adhesion and chemotaxis [J].
Dastych, J ;
Taub, D ;
Hardison, MC ;
Metcalfe, DD .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 275 (05) :C1291-C1299
[19]   Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family [J].
de Groot, RP ;
Coffer, PJ ;
Koenderman, L .
CELLULAR SIGNALLING, 1998, 10 (09) :619-628
[20]  
Engelhardt M, 1997, BLOOD, V90, P182